Zealand Pharma AS (ZEAL) Stock Analyst Ratings
NASDAQ:ZEAL - Nasdaq - US98920Y3045 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to ZEAL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 28.31. This target is 60.93% above the current price.
ZEAL was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ZEAL.
In the previous month the buy percentage consensus was at a similar level.
ZEAL was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-13 | Needham | Maintains | Buy |